Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis

In patients with epidermal growth factor receptor (EGFR)-mutant non–small-cell lung cancer (NSCLC) with brain metastases, it remains controversial whether the use of EGFR-tyrosine kinase inhibitor (TKI) alone without radiotherapy (RT) is an optimal approach. Here, we investigated the clinical outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Dong-gon, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162462/
https://www.ncbi.nlm.nih.gov/pubmed/32298306
http://dx.doi.org/10.1371/journal.pone.0231546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162462/
https://www.ncbi.nlm.nih.gov/pubmed/32298306
http://dx.doi.org/10.1371/journal.pone.0231546

Ejemplares similares